Immunovant, Inc.
Immunovant is a clinical-stage immunology company developing anti-FcRn targeted therapies for autoimmune diseases.
8-KSep 3Latest SEC filing, period to Sep 2
Aug 6Latest story
August 2026
Sign inSign inImmunovant is a clinical-stage immunology company developing anti-FcRn targeted therapies for autoimmune diseases.